Tylenol Precise is Kenvue’s First US Product Launch Since Its Publicly Traded Status

Kenvue, a Happi Top 50 Company, has announced its first US product launch since it became publicly traded. 

 

Tylenol Precise builds on “decades of science innovation brought about by consumer-led insights,” said the company.

 

Tylenol created a gel cream topical to provide maximum strength lidocaine (4%) without a prescription. The massaging rollerball applicator delivers targeted pain relief.

The development of this product also addresses a need for the brand—it revealed 73% of Tylenol users also apply topicals for pain relief.